# Psilocybin-Assisted Cognitive Processing Therapy for Chronic PTSD

> **NCT06386003** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Unity Health Toronto** · enrollment: 15 (estimated)

## Conditions studied

- Post Traumatic Stress Disorder
- PTSD
- Chronic PTSD

## Interventions

- **DRUG:** Psilocybin

## Key facts

- **NCT ID:** NCT06386003
- **Lead sponsor:** Unity Health Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-01-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06386003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06386003, "Psilocybin-Assisted Cognitive Processing Therapy for Chronic PTSD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06386003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*